BEOVU

What is this medication? Beovu is a prescription medication used to treat adults with neovascular age-related macular degeneration, also known as wet AMD. It is also approved for the treatment of diabetic macular edema. This medication belongs to a class of drugs called vascular endothelial growth factor inhibitors, which work by blocking a specific protein that promotes the growth of abnormal and leaky blood vessels in the retina. By targeting this protein, the drug helps reduce fluid buildup and swelling in the back of the eye.

The treatment is administered by a healthcare professional as an injection directly into the eye. The primary goal of using this medication is to help maintain or improve vision and prevent the progression of sight loss caused by fluid leakage. Patients receiving this therapy are typically monitored closely by an ophthalmologist to evaluate the effectiveness of the treatment and to manage any potential side effects related to eye inflammation or pressure.